Surging global burdens of treatment-refractory hematological malignancies, expanding clinical validation of precision gene editing, and continuous biopharmaceutical innovations in autologous cell engineering are driving rapid growth across the global Personalized Cell Therapy Market. Personalized cell therapy solutions—comprising Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies,...